FEATURED

RKLB Joined the Nasdaq-100. Now SpaceX Is Public.

Two things happened to Rocket Lab in the same week. On June 22, RKLB officially joined the Nasdaq-100 Index, putting it inside the major Nasdaq-100-tracking ETFs and index products. And on June 12, SpaceX debuted on the Nasdaq under the ticker SPCX, priced at $135 per share with an IPO valuation of $1.77 trillion, the largest IPO in history. Its market cap hit roughly $2.1 trillion on the first day of trading.

That combination is why RKLB sold off on inclusion day. And why it is still the most interesting space story in public markets right now.

Analyst Targets

• KeyBanc: Upgraded to Overweight, $135 price target (June 15)
• Street consensus (S&P Global, 19 analysts): ~$106.92 average; analyst range of $60 to $150
• Consensus rating: Buy, with no sell ratings among covering analysts

The Business Right Now

Rocket Lab reported Q1 2026 revenue of $200.3 million, a 63.5% year-over-year increase. That number beat management guidance on revenue, gross margin, and adjusted EBITDA. The company guided Q2 2026 revenue to $225–$240 million, and the analyst consensus Q2 revenue estimate sits near $236.6 million, suggesting the growth rate is holding.

The backlog is the number that matters most: $2.2 billion as of Q1, up 108% from the prior year. That is locked-in future revenue. Not projections. Contracts.

• Q1 2026 revenue: $200.3 million (+63.5% YoY)
• Q2 2026 revenue guidance: $225 million to $240 million
• Contract backlog: $2.2 billion (+108% YoY)
• Total launch manifest: 70+ contracted missions
• 52-week range: $31.78 to $151.00
• Current price (June 24 close): $85.41
• Q2 earnings date (est.): August 5–6, 2026

Why the Defense Story Is Bigger Than People Realize

The part people skip: Rocket Lab is not primarily a launch company anymore. Its Space Systems segment now accounts for roughly two-thirds of revenue. And its defense contract portfolio is substantial. The company holds an $816 million Space Development Agency Tracking Layer Tranche 3 satellite award, a $190 million HASTE hypersonic contract covering 20 launches, a $90 million GEO surveillance award to build and operate two GEO satellites hosting the Heimdall space domain awareness payload, and a $24 million Neutron upper-stage development award. Combined with an earlier approximately $515 million Transport Layer-Beta Tranche 2 award, total SDA contracts now exceed $1.3 billion.

The company also completed the acquisition of Mynaric in April 2026, adding space-based laser communications to its portfolio. It completed the acquisition of Motiv Space Systems in May 2026, adding Mars-proven robotics capabilities. And it was selected alongside Raytheon to demonstrate capabilities for the U.S. Space Force Space Based Interceptor program. This is not a small satellite company anymore.

What is interesting is that all of this happened with almost no attention. The SpaceX IPO absorbed nearly all of the space sector news flow, and RKLB drifted lower while its fundamentals kept improving.

The SpaceX Dynamic

Here is where it gets complicated. Before SpaceX went public, Rocket Lab was a primary way institutional investors got pure-play space exposure. That scarcity premium was real. Now SpaceX trades on the Nasdaq at a market cap that hit roughly $2.1 trillion on its first day, and investors who want the dominant space franchise can own it directly. As of June 22, SPCX was trading near $165, which is down roughly 27% from its intraday peak but still well above the $135 IPO price.

The question is not whether SpaceX is better. It clearly is, at scale. The question is whether the valuation gap between a multi-trillion-dollar company and Rocket Lab makes RKLB the more interesting risk-reward. On revenue multiples alone, RKLB trades at a fraction of SpaceX’s implied multiple, with faster near-term growth rates and a more concentrated catalyst calendar.

Three Scenarios

Bull: Neutron successfully launches in Q4 2026, Rocket Lab becomes the only Western alternative to SpaceX for medium-lift payloads. Defense backlog keeps expanding. Stock moves back toward $130–$150. The Nasdaq-100 inclusion drives durable passive fund buying that supports the multiple.

Base: Neutron faces a one-to-two quarter delay, Space Systems and Electron continue growing on plan, defense contracts provide revenue stability. Stock consolidates in the $85–$110 range through year-end and re-rates on Neutron news.

Bear: Neutron maiden launch fails. Investors rotate into SpaceX directly. Index inclusion flows dissipate. Stock revisits low $70s or lower. The company remains unprofitable and the timeline to profitability shifts materially to the right.

Technical Framework

RKLB set a 52-week high of $151.00 on May 27, then sold off sharply into the SpaceX IPO and Nasdaq-100 inclusion window. It closed June 24 at $85.41, down roughly 43% from that high. The stock has found some accumulated volume support near the $82–$83 zone. A confirmed reclaim of the $95–$100 area, where the previous breakout level overlaps with short-term moving averages, would improve the near-term picture. A decisive close below $83 opens downside toward $75–$80. Volatility remains elevated, with the beta near 2.6 and daily ranges frequently running 8–12%.

What Traders Are Watching

• Neutron development updates: any timeline shift, positive or negative, is a binary catalyst for the stock
• Defense contract pipeline: additional Space Force, SDA, or hypersonic awards would reinforce the growth theme
• Passive fund flows: Nasdaq-100 inclusion affects $1.4 trillion in total notional value across ETFs, mutual funds, and structured products
• SpaceX trading behavior: how institutional money allocates between the two names will determine whether RKLB’s remaining premium holds
• Q2 earnings: expected around August 5–6, with consensus revenue near $236.6 million and continued backlog conversion

Bottom Line

Rocket Lab earned its Nasdaq-100 seat. The fundamentals back it. Record revenue, record backlog, meaningful defense contracts totaling over $1.3 billion with the SDA alone, and a Neutron launch schedule that could reshape the competitive landscape for medium-lift entirely.

What changed is the benchmark. SpaceX went public in June, around the same time RKLB joined the index. From here, every RKLB trading day happens in direct comparison to the largest IPO in market history. That is not necessarily bad. It just means the scarcity premium that used to support this stock needs to be replaced by execution. And Neutron is the execution test that determines whether it happens.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.